Use the search parameters below to filter talks:

Calendar
Calendar

26th International Congress of The Transplantation Society (Hong Kong)

Outcomes of Pancreas Tx
20 August 2016  /  10:30 - 12:30

Long term results in pancreas re transplantation depending on the cause of primary graft failure

Presenter: Lilia Martinez de la Maza, Barcelona, Spain

- Long term results in pancreas re transplantation depending on the cause of primary graft failure

Presenter: Lilia Martinez de la Maza, Barcelona, Spain

The optimal range of native kidney function before pancreas transplant alone minimizing the risk of end-stage renal disease

Presenter: Sung Shin, Seoul, Korea

- The optimal range of native kidney function before pancreas transplant alone minimizing the risk of end-stage renal disease

Presenter: Sung Shin, Seoul, Korea

Hyperinsulinemia after pancreas transplantation: a risk for excessive weight gain, metabolic syndrome, and fatty liver disease

Presenter: Richard J. Knight, Houston, United States

- Hyperinsulinemia after pancreas transplantation: a risk for excessive weight gain, metabolic syndrome, and fatty liver disease

Presenter: Richard J. Knight, Houston, United States

The prediction of the endocrine function of the graft using contrast-enhanced ultrasonography in clinical pancreas transplantation

Presenter: Naohiro Aida, Toyoake, Japan

- The prediction of the endocrine function of the graft using contrast-enhanced ultrasonography in clinical pancreas transplantation

Presenter: Naohiro Aida, Toyoake, Japan

Antibody Mediated Injury
20 August 2016  /  10:30 - 12:30

Pretransplant AT1Rabs are associated with acute rejection in 2-haplotypes kidney transplant recipients.

Presenter: Jose Manuel Arreola, Aguascalientes, Mexico

- Pretransplant AT1Rabs are associated with acute rejection in 2-haplotypes kidney transplant recipients.

Presenter: Jose Manuel Arreola, Aguascalientes, Mexico

Preformed C1q-binding DSA are more clearly associated with adverse outcomes after HLA-incompatible kidney transplantation than DSA strength

Presenter: Jorge Malheiro, Porto, Portugal

- Preformed C1q-binding DSA are more clearly associated with adverse outcomes after HLA-incompatible kidney transplantation than DSA strength

Presenter: Jorge Malheiro, Porto, Portugal

De novo donor specific antibodies in kidney transplantation - a systematic review and meta-analysis

Presenter: Ankit Sharma, Westmead, Australia

- De novo donor specific antibodies in kidney transplantation - a systematic review and meta-analysis

Presenter: Ankit Sharma, Westmead, Australia

Do We Know How to Treat Resistant Antibody-Mediated Rejection Effectively? A Single Centre Experience

Presenter: Janka Slatinska, Prague, Czech Republic

- Do We Know How to Treat Resistant Antibody-Mediated Rejection Effectively? A Single Centre Experience

Presenter: Janka Slatinska, Prague, Czech Republic

EARLY ACUTE HUMORAL REJECTION IN THE ABSENCE OF ANTI-HLA ANTIBODIES: CLINICO-PATHOLOGICAL DESCRIPTION FROM A FRENCH NATION-WIDE STUDY

Presenter: Marianne Delville, Paris, France

- EARLY ACUTE HUMORAL REJECTION IN THE ABSENCE OF ANTI-HLA ANTIBODIES: CLINICO-PATHOLOGICAL DESCRIPTION FROM A FRENCH NATION-WIDE STUDY

Presenter: Marianne Delville, Paris, France

Correlation Between C3d-fixing Donor Specific HLA Antibody and Luminex MFI

Presenter: Lionel Rostaing, Toulouse, France

- Correlation Between C3d-fixing Donor Specific HLA Antibody and Luminex MFI

Presenter: Lionel Rostaing, Toulouse, France

The natural history of donor specific antibodies in kidney transplant recipients and associated clinical outcomes

Presenter: Susan Wan, Ultimo, Australia

- The natural history of donor specific antibodies in kidney transplant recipients and associated clinical outcomes

Presenter: Susan Wan, Ultimo, Australia

Urine IP-10 as the Biomarker for ABMR in Kidney Transplant Recipient with DGF

Presenter: Natavudh Townamchai, Bangkok, Thailand

- Urine IP-10 as the Biomarker for ABMR in Kidney Transplant Recipient with DGF

Presenter: Natavudh Townamchai, Bangkok, Thailand

Clinical Outcomes: Heart transplants and VADs
20 August 2016  /  10:30 - 12:30

Terlipressin Increases Blood Pressure and Facilitates Weaning from Cardiopulmonary Bypass in Heart Transplant Recipients with Refractory Hypotension

Presenter: Zeynep Ersoy, Ankara, Turkey

- Terlipressin Increases Blood Pressure and Facilitates Weaning from Cardiopulmonary Bypass in Heart Transplant Recipients with Refractory Hypotension

Presenter: Zeynep Ersoy, Ankara, Turkey

Pre-Orthotopic Heart Transplant (OHT) Estimated Glomerular Filtration Rate (eGFR) Predicts Post-OHT Mortality and Renal Outcomes

Presenter: Hani Wadei, Jackosonville, United States

- Pre-Orthotopic Heart Transplant (OHT) Estimated Glomerular Filtration Rate (eGFR) Predicts Post-OHT Mortality and Renal Outcomes

Presenter: Hani Wadei, Jackosonville, United States

Relationship between Brachial Artery Flow-mediated Dilation and Clinical Characteristics in Heart Transplant Recipients

Presenter: Takuya Watanabe, Osaka, Japan

- Relationship between Brachial Artery Flow-mediated Dilation and Clinical Characteristics in Heart Transplant Recipients

Presenter: Takuya Watanabe, Osaka, Japan

Effects of Exercise Training on Cardiac Reserve and Autonomic Activity in Post Heart Transplant Patients and Patients Receiving Left Ventricular Assist Devices Support by Assessment of Heart Rate Profile

Presenter: Katherine Fan, Aberdeen, Hong Kong

- Effects of Exercise Training on Cardiac Reserve and Autonomic Activity in Post Heart Transplant Patients and Patients Receiving Left Ventricular Assist Devices Support by Assessment of Heart Rate Profile

Presenter: Katherine Fan, Aberdeen, Hong Kong

Physical Function And Self-reported Health Status In Pre-transplant Patients with Left Ventricular Assisted Device - Local Experience of Out-Patient Cardiac Rehabilitation Program in Hong Kong

Presenter: Jenny Ng, Hong Kong, Hong Kong

- Physical Function And Self-reported Health Status In Pre-transplant Patients with Left Ventricular Assisted Device - Local Experience of Out-Patient Cardiac Rehabilitation Program in Hong Kong

Presenter: Jenny Ng, Hong Kong, Hong Kong

Is perfect long-term result of continuous-flow LVAD for bridge to transplantation possible?

Presenter: Minoru Ono, Tokyo, Japan

- Is perfect long-term result of continuous-flow LVAD for bridge to transplantation possible?

Presenter: Minoru Ono, Tokyo, Japan

Metabolic Profile of Donation after Circulatory Death Hearts during Reconditioning

Presenter: Hong Chee Chew, Kingsgrove, Australia

- Metabolic Profile of Donation after Circulatory Death Hearts during Reconditioning

Presenter: Hong Chee Chew, Kingsgrove, Australia

LOW MOLECULAR WEIGHT HEPARINE AS ALTERNATIVE ANTICOAGULATION THERAPY IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES

Presenter: Bahadir Gültekin, ANKARA, Turkey

- LOW MOLECULAR WEIGHT HEPARINE AS ALTERNATIVE ANTICOAGULATION THERAPY IN PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES

Presenter: Bahadir Gültekin, ANKARA, Turkey

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi